# Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia

> **NCT00234481** · PHASE1 · TERMINATED · sponsor: **Exelixis**

## Conditions studied

- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma

## Interventions

- **DRUG:** XL844

## Key facts

- **NCT ID:** NCT00234481
- **Lead sponsor:** Exelixis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Why stopped:** Study closed due to slow enrollment
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234481, "Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00234481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*